Hospitalizations for thyrotoxicosis in childhood in Brazil and its regions between 2010 and 2019
Main Article Content
Abstract
Introduction: Thyrotoxicosis is a clinical manifestation caused by elevated serum levels of thyroid hormones, with Graves disease being the most prevalent cause of this condition in children. Thyrotoxicosis is marked by an acute clinical course, requiring medical support and
evaluation. Objectives: Describe the epidemiological, clinical and budgetary aspects of pediatric patients with thyrotoxicosis in Brazil between 2010 and 2019. Methodology: This was an ecological study based on secondary data obtained from DATASUS. The population
consisted of children hospitalized for thyrotoxicosis from 2010 to 2019 in Brazil. Results: There was a total of 414 admissions, 70.29% of which were urgent. Females accounted for 77.78%, while males accounted for 22.22%. The Southeast registered 217 hospitalizations
(52.42%), being also the region with the highest average cost per hospitalization (R$638.9). The highest concentration of hospitalizations occurred in the 15-19 age group. During the study period, there was a 48.15% increase in hospitalizations. Conclusion: The findings
of this study correlate with those described in previous studies. The results obtained reinforce the importance of further studies to better understand this clinical condition in the health system scenario.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Rodanaki M, Lodefalk M, Forssell K, Arvidsson CG, Forssberg M, Åman J. The Incidence of Childhood Thyrotoxicosis Is Increasing in Both Girls and Boys in Sweden. Horm Res Paediatr. 2019;91(3):195-202. doi:10.1159/000500265
2. Gill DS, Greening JE, Howlett TA, Levy MJ, Shenoy SD. Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience. Journal of Pediatric Endocrinology and Metabolism. 2019;32(2):151-157. https://doi.org/10.1515/jpem-2018-0385
3. De Luca F, Valenzise M. Controversies in the pharmacological treatment of Graves' disease in children. Expert Review of Clinical Pharmacology. 2018;11(11):1113-1121, DOI: 10.1080/17512433.2018.1546576
4. Maia AL, et al. Consenso brasileiro para o diagnóstico e tratamento do hipertireoidismo: recomendações do Departamento de Tireoide da Sociedade Brasileira de Endocrinologia e Metabologia. Arquivos Brasileiros de Endocrinologia & Metabologia. 2013;57(3):205-232. Disponível em: <https://doi.org/10.1590/S0004-27302013000300006>. Acesso em: 6 jun. 2021.
5. Wood CL, Cole M, Donaldson M, Dunger DB, Wood R, Morrison N, Matthews JNS, Pearce SHS, Cheetham TD. Randomised trial of block and replace vs dose titration thionamide in young people with thyrotoxicosis. Eur J Endocrinol. 2020 Dec;183(6):637-645. doi: 10.1530/EJE-20-0617. PMID: 33107439.
6. Brasil. Ministério da Saúde. Departamento de Informática do SUS. Sistema de Informações Hospitalares Descentralizado [Internet]. Brasília: Ministério da Saúde; 2015. Disponível em: <http://www2.datasus.gov.br/DATASUS/index.php?area=0901&item=1&acao=25>.
7. Brasil. Ministério da Saúde. Departamento de Informática do SUS. Código Internacional de Doenças (CID- 10) [Internet]. Brasília: Ministério da Saúde; 2015. Disponível em: <http://datasus.saude.gov.br/sistemas-e-aplicativos/cadastros-nacionais/cid-10>.
8. Bahia. Secretaria de Saúde do Estado. Regiões de Saúde do Estado da Bahia [Internet]. Salvador: Secretaria de Saúde do Estado; 2015 Disponível em: <http://www1.saude.ba.gov.br/mapa_bahia/indexch.asp>
9. Weber EM, Mallmann BLK, Tonini CRA, Landivar EEC, Daiprai TM, Vidigal TMA. Epidemiologia dos Transtornos da tireoide no estado de Santa Catarina no período de 2008 a 2015. Unoesc & Ciência - ACBS Joaçaba. 2017;8(1):43-50.
10. Viana V, et al. Relato de caso: doença de Graves. Revista de Iniciação Científica da Universidade Vale do Rio Verde.2015;5(1). Disponível em: RELATO DE CASO: Doença de Graves | VIANA | Revista de Iniciação Científica da Universidade Vale do Rio Verde (unincor.br).
11. Barroso CF, et al. Estado nutricional relativo ao zinco em pacientes com hipertireoidismo. Nutrire. 2012;37:27-33. Disponível em: ReP USP - Detalhe do registro: Estado nutricional relativo ao zinco em pacientes com hipertireoidismo.
12. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios (PNAD) 2019. Disponível em: http://www.ibge.gov.br.
13. Da Silva AS, et al. Principais distúrbios tireoidianos e suas abordagens na atenção primária à saúde. Revista da AMRIGS. 2011;55(4):380-388. Disponível em: https://www.researchgate.net/profile/Anderson_Silva33/publication/282704252_A_Primary_Care_Approach_to_Main_Thyroid_Disorders/links
/5619348b08ae044edbaf8ac6.pdf.
14. Maia AL, Scheffel RS, Meyer ELS, Mazeto GMFS, Carvalho GA, Graf H, Vaisman M, Maciel LMZ, Ramos HE, Tincani AJ, Andrada NC, Ward LS. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metab. 2013;57(3).
15. Sharma A, Stan MN. Thyrotoxicosis: Diagnosis and Management. 2019;94(6):1048-1064. DOI: https://doi.org/10.1016/j.mayocp.2018.10.011
16. Sandrini R, França SN, Lacerda L, Graf H. Tratamento do hipertireoidismo na infância e adolescência. Arq Bras Endocrinol Metab. 2001;45(1). Disponível em: <https://doi.org/10.1590/S0004-27302001000100006>.